LBSUN207 Efficacy And Safety Of Degludec U100 Versus Glargine U300 For The Hospital Management Of Patients With Type 2 Diabetes: A Prospective, Open-label, Non-inferiority Randomized Controlled Trial

AIMS: No head-to-head comparisons of two ultra-long acting insulins, degludec-100 and glargine-300, have been reported in the inpatient setting. We compared the efficacy and safety of these two insulins for the hospital management of patients with type 2 diabetes (T2D). METHODS: This target-to-treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuchay, Mohammad Shafi, Mathew, Anu, Mishra, Mitali, Parvathi, S, Kaur, Parjeet, Wasir, Jasjeet Singh, Gill, Harmandeep Kaur, Jain, Rujul, Gagneja, Sakshi, Kohli, Chhavi, Kumari, Poonam, Singh, Manish Kumar, Mishra, Sunil Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Diabetes & Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624859/
http://dx.doi.org/10.1210/jendso/bvac150.587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624859/
http://dx.doi.org/10.1210/jendso/bvac150.587

Ejemplares similares